Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Another SSRI success story: sertraline safe and effective in patients with panic disorder

Sep. 23, 1998

Sodium channel blocker with antiischemic potential emerges from Glaxo Wellcome R&D

Sep. 22, 1998

Another mGluR1 receptor ligand reported by Lilly

Sep. 22, 1998

Kyowa Hakko reports success in its search for new analgesics

Sep. 22, 1998

Toa Eiyo discloses new adenosine A1 antagonists

Sep. 22, 1998

Nortran completes phase II trial of RSD-921

Sep. 22, 1998

Cognition enhancer on the clinical track at Dainippon

Sep. 21, 1998

Orion receives EU approval to market Parkinson's disease treatment

Sep. 21, 1998

Anergen in-licenses MHC II-peptide complex with potential applications in MS

Sep. 21, 1998

Search for 5-HT2C ligands at Organon leads to the full agonist Org-38457

Sep. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...